Welcome Enhanced Perinatal Surveillance (EPS) Meeting

1. Welcome Enhanced Perinatal Surveillance (EPS) Meeting

2. Number of cases

3. Milestones of Perinatal Prevention • 1994 076 trial ZDV reduced mother-to child-transmission • 1995-USPHS recommends voluntary HIV test for all pregnant women • 1999- IOM issues report Reducing the Odds: Preventing Perinatal Transmission of HIV in the U.S. • 1999-Congress appropriated $10 million per year for activities aimed at reducing perinatal HIV infection including Enhanced Perinatal HIV Surveillance, funded in 24 state and local health departments including Texas and Houston • 2001- Revised recommendations HIV screening for pregnant women including rapid testing • 2003-CDC releases Advancing HIV Prevention Initiative

4. Advancing HIV Prevention-CDC4 Strategies 1.Incorporate HIV testing as a routine part of care in traditional medical settings. 2. Implement new models for diagnosing HIV infections outside medical settings. • Prevent new infections by working with people diagnosed with HIV and their partners. • Further decrease perinatal HIV transmission.

5. Advancing HIV Prevention • Treatment of pregnant women and their infants can substantially reduce the number of babies born with HIV infection. Such interventions are most effective when the HIV status of the pregnant woman is known as early as possible in pregnancy –and if not known—when the baby can be tested at the time of birth. • CDC will: • Promote screening of every pregnant woman for HIV, using the “opt-out” approach. Make prenatal HIV screening a routine part of medical care. • Promote screening of newborns whose mothers HIV status is not known.

6. Where does Enhanced Perinatal Surveillance fit in? Goals of EPS • Monitor and describe: HIV testing of pregnant women, use of antiretrovirals to prevent perinatal HIV transmission, and trends of HIV disease among perinatally infected children • Evaluate perinatal prevention efforts